NCT07617857

Brief Summary

This randomized crossover study investigated the effects of whole-body cryotherapy (WBC) on isokinetic knee performance following running-induced fatigue in physically active healthy male university students. Participants completed two recovery conditions, WBC and passive rest, on separate days following a standardized treadmill fatigue protocol. Knee extension and flexion strength were assessed using an isokinetic dynamometer at angular velocities of 60°/s and 240°/s. In addition, blood pressure, heart rate, oxygen saturation, and perceived fatigue responses were monitored throughout the recovery period. The study aimed to determine whether WBC improves post-exercise recovery and lower-extremity muscle performance compared with passive rest.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 2, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

May 24, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 1, 2026

Completed
Last Updated

June 2, 2026

Status Verified

May 1, 2026

Enrollment Period

8 months

First QC Date

May 24, 2026

Last Update Submit

June 1, 2026

Conditions

Keywords

Whole-Body CryotherapyCryotherapyExercise-Induced FatigueRecoveryIsokinetic Dynamometer

Outcome Measures

Primary Outcomes (2)

  • Peak Torque During Knee Extension and Flexion

    Assessment of isokinetic knee extension and flexion peak torque at 60°/s and 240°/s following whole-body cryotherapy and passive rest recovery conditions.

    Immediately after the 30-minute recovery period

  • Peak Torque Normalized to Body Mass

    Assessment of body mass-normalized peak torque values during isokinetic knee extension and flexion testing at 60°/s and 240°/s.

    Immediately after the 30-minute recovery period

Secondary Outcomes (4)

  • Heart Rate

    Baseline, immediately after exercise, and every 5 minutes during the 30-minute recovery period

  • Blood Pressure

    Baseline, immediately after exercise, and every 5 minutes during the 30-minute recovery period

  • Oxygen Saturation

    Baseline, immediately after exercise, and every 5 minutes during the 30-minute recovery period

  • Perceived Fatigue

    Immediately after exercise, 5 minutes, and 10 minutes after exercise

Study Arms (2)

Whole-Body Cryotherapy

EXPERIMENTAL

Participants underwent whole-body cryotherapy following the running-induced fatigue protocol.

Procedure: Whole-Body Cryotherapy

Passive Rest

NO INTERVENTION

Participants completed passive seated rest following the running-induced fatigue protocol.

Interventions

Participants underwent whole-body cryotherapy following a standardized running-induced fatigue protocol. The intervention was performed in a two-stage cryogenic chamber consisting of a 30-second adaptation phase at -30°C followed by a 3-minute exposure at -85°C.

Whole-Body Cryotherapy

Eligibility Criteria

Age18 Years - 30 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy male participants aged 18-30 years with no exercise limitation
  • No history of knee or lower-extremity injury requiring physiotherapy or surgical intervention
  • No current lower-extremity pain
  • No limitation in lower-extremity range of motion
  • No chronic disease
  • No mental or psychological disorder

You may not qualify if:

  • Presence of cardiovascular disease
  • Presence of respiratory disease
  • History of cold allergy
  • Presence of a tumor-related disease
  • Presence of a viral or bacterial infection
  • Diagnosis of Raynaud's disease
  • Presence of claustrophobia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul University

Istanbul, Istanbul, 34000, Turkey (Türkiye)

Location

Related Publications (4)

  • Krueger M, Costello JT, Achtzehn S, Dittmar KH, Mester J. Whole-body cryotherapy (-110 degrees C) following high-intensity intermittent exercise does not alter hormonal, inflammatory or muscle damage biomarkers in trained males. Cytokine. 2019 Jan;113:277-284. doi: 10.1016/j.cyto.2018.07.018. Epub 2018 Jul 19.

  • Abaidia AE, Lamblin J, Delecroix B, Leduc C, McCall A, Nedelec M, Dawson B, Baquet G, Dupont G. Recovery From Exercise-Induced Muscle Damage: Cold-Water Immersion Versus Whole-Body Cryotherapy. Int J Sports Physiol Perform. 2017 Mar;12(3):402-409. doi: 10.1123/ijspp.2016-0186. Epub 2016 Aug 24.

  • Wilson LJ, Cockburn E, Paice K, Sinclair S, Faki T, Hills FA, Gondek MB, Wood A, Dimitriou L. Recovery following a marathon: a comparison of cold water immersion, whole body cryotherapy and a placebo control. Eur J Appl Physiol. 2018 Jan;118(1):153-163. doi: 10.1007/s00421-017-3757-z. Epub 2017 Nov 10.

  • Rose C, Edwards KM, Siegler J, Graham K, Caillaud C. Whole-body Cryotherapy as a Recovery Technique after Exercise: A Review of the Literature. Int J Sports Med. 2017 Dec;38(14):1049-1060. doi: 10.1055/s-0043-114861. Epub 2017 Nov 21.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Participants completed both recovery conditions (whole-body cryotherapy and passive rest) in a randomized crossover manner on separate days following a standardized running-induced fatigue protocol. Each participant served as his own control, and sessions were separated by at least 48 hours.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 24, 2026

First Posted

June 1, 2026

Study Start

September 2, 2024

Primary Completion

May 1, 2025

Study Completion

May 1, 2025

Last Updated

June 2, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations